{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:14:28Z","timestamp":1789330468375,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ijcard.2022.11.024","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:11:51Z","timestamp":1668805911000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease: An epidemiological study in UK Biobank and Oxford Biobank"],"prefix":"10.1016","volume":"373","author":[{"given":"Kyriaki","family":"Pieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Trichia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Karpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Koivula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcard.2022.11.024_bb0005","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J. Lipid Res."},{"issue":"5629","key":"10.1016\/j.ijcard.2022.11.024_bb0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/269604a0","article-title":"Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man","volume":"269","author":"Utermann","year":"1977","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijcard.2022.11.024_bb0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ejhg.2008.202","article-title":"The expression of type III hyperlipoproteinemia: involvement of lipolysis genes","volume":"17","author":"Henneman","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"issue":"2, Part 2","key":"10.1016\/j.ijcard.2022.11.024_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-8703(87)90610-7","article-title":"Apolipoprotein E polymorphism in health and disease","volume":"113","author":"Utermann","year":"1987","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2022.11.024_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2021.04.001","article-title":"Adiposity and the development of dyslipidemia in APOE &#x3b5;2 homozygous subjects: a longitudinal analysis in two population-based cohorts","volume":"325","author":"Heidemann","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcard.2022.11.024_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10408363.2013.870526","article-title":"Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E","volume":"51","author":"Marais","year":"2014","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"6","key":"10.1016\/j.ijcard.2022.11.024_bb0035","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacl.2018.09.006","article-title":"The spectrum of type III hyperlipoproteinemia","volume":"12","author":"Sniderman","year":"2018","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.11.024_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0004.1979.tb02027.x","article-title":"Polymorphism of apolipoprotein E","volume":"15","author":"Utermann","year":"1979","journal-title":"Clin. Genet."},{"issue":"12","key":"10.1016\/j.ijcard.2022.11.024_bb0045","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ijcard.2022.11.024_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx132","article-title":"Cohort profile: the Oxford Biobank","volume":"47","author":"Karpe","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"7726","key":"10.1016\/j.ijcard.2022.11.024_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijcard.2022.11.024_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcard.2022.11.024_bb0065","series-title":"UK Biobank Biomarker Project. Companion Document to Accompany Serum Biomarker Data. Version 1.0","author":"UK Biobank","year":"2019"},{"key":"10.1016\/j.ijcard.2022.11.024_bb0070","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"issue":"43","key":"10.1016\/j.ijcard.2022.11.024_bb0075","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"issue":"7","key":"10.1016\/j.ijcard.2022.11.024_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.ijcard.2022.11.024_bb0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.ijcard.2022.11.024_bb0090","series-title":"Genotyping and quality control of UK Biobank, a large-scale, extensively phenotyped prospective resource. Information for researchers. v1.2 Oct 2015. Interim Data Release 2015","author":"UK Biobank","year":"2015"},{"key":"10.1016\/j.ijcard.2022.11.024_bb0095","series-title":"Biomarker assay quality procedures: approaches used to minimise systematic and random errors (and the wider epidemiological implications). Version 1.2","author":"UK Biobank","year":"2019"},{"issue":"8","key":"10.1016\/j.ijcard.2022.11.024_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet. Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.ijcard.2022.11.024_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006812","article-title":"Ranking and characterization of established BMI and lipid associated loci as candidates for gene-environment interactions","volume":"13","author":"Shungin","year":"2017","journal-title":"PLoS Genet."},{"issue":"9874","key":"10.1016\/j.ijcard.2022.11.024_bb0110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcard.2022.11.024_bb0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.ijcard.2022.11.024_bb0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ajcn\/77.3.573","article-title":"Effect of sex and obesity on basal VLDL-triacylglycerol kinetics","volume":"77","author":"Mittendorfer","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ijcard.2022.11.024_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.ijcard.2022.11.024_bb0130","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennet","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcard.2022.11.024_bb0135","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1038\/s41598-021-88256-x","article-title":"Age and sex specific effects of APOE genotypes on ischemic heart disease and its risk factors in the UK Biobank","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2022.11.024_bb0140","first-page":"59","article-title":"Apolipoprotein E (<em>APOE<\/em>) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank","author":"Lumsden","year":"2020","journal-title":"EBioMedicine"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322017119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322017119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:00:06Z","timestamp":1759093206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322017119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"alternative-id":["S0167527322017119"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.11.024","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polygenic risk in Type III hyperlipidaemia and risk of cardiovascular disease: An epidemiological study in UK Biobank and Oxford Biobank","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}